Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9063429.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pseudotumor cerebri is generally a benign disorder. It has been reported to occur in hypothyroidism, particularly after the initiation of L-thyroxine replacement therapy. Previous case reports have involved children primarily in the peripubertal age range (approximately 8 to 13 years). We report here the development of pseudotumor cerebri in an infant who required treatment with L-thyroxine for transient neonatal hypothyroidism as a result of maternal thyroid-stimulating hormone receptor-blocking antibodies.
Medical subject headings
- Hypothyroidism
- Pseudotumor Cerebri
- Thyroxine